Clinical Trial Update: VI-1121 for the Treatment Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of VI-1121 for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• VI-1121

Snippet

Sponsor: VIVUS LLC | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED